Ignite Creation Date:
2024-05-06 @ 2:51 PM
Last Modification Date:
2024-10-26 @ 1:38 PM
Study NCT ID:
NCT04441918
Status:
UNKNOWN
Last Update Posted:
2020-06-22
First Post:
2020-06-06
Brief Title:
TolerabilitySafetyPharmacokinetic Profile and Immunogenicity of a Recombinant Humanized Anti-SARS-CoV-2 Monoclonal Antibody JS016 for Injection in Chinese Health Subjects
Sponsor:
Organization:
Shanghai Junshi Bioscience Co Ltd